Clinical Trial Supply: Trends & Practices 2012/2013

We respect your privacy, by submitting this form you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest subject to their privacy policy. For further information on how we process and monitor your personal data, and information about your privacy and opt-out rights click here. By clicking the "Download button" you agree to the terms of our Privacy Policy.

What are your priorities for your clinical trial supply in 2013? Pharma IQ recently published the results of an industry-led clinical trials supply survey.
Download this report and discover how to:
  • Reduce overage through implementing product pooling and just in time labelling with strategies from our expert advisory panel
  • Leverage outsourcing opportunities by learning best practice in distribution and logistics
  • Get to grips with GDP regulations to understand the latest requirements for controlled room temperature


4 Key findings from the report include:

  1. Supporting numerous clinical trials is the main priority for respondents for the next 5 years
  2. 42% run between 1 and 10 active trials annually
  3. 71% predict the number of trials in BRIC countries to increase in the next 12 month
  4. China was selected as the most likely popular destination for clinical trials in the next 5 years at 35.4%
This survey report was created as a part of the pre-conference research for the 3rd Annual Clinical Supply Europe, Congress Centre Basel, Switzerland - 30th January  - 1st February